Ovitrelle 250 µg, Injektionslösung in einer Fertigspritze

7680563640078 CH-56364 Injektionslösung

Associated product:

OVITRELLE sol inj 250 mcg/0.5 ml ser pré 0.5 ml
Ovitrelle 250 µg, Injektionslösung in einer Fertigspritze
Ovitrelle 250 µg, Injektionslösung in einer Fertigspritze
Ovitrelle 250 µg, Injektionslösung in einer Fertigspritze
1 / 3
google

Article details

Package size
1
Selling units
1
Measure
Spritze(n)
Galenic form
Injektionslösung
Galenic group
Injektion/Infusion

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
09/08/2021
Patient information leaflet
Français
09/08/2021
Patient information leaflet
Italien
09/08/2021
Summary of Product Characteristics
Allemand
09/08/2021
Summary of Product Characteristics
Français
09/08/2021
Summary of Product Characteristics
Italien
09/08/2021

Detailed composition

Substance Quantity Type Category
(N/A)
250.0 UG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
0.1 MG Substance HBESI
(N/A)
- Substance ANTOX
(N/A)
- Substance HNIDK

Reimbursement information

Public price
CHF 49.85
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/04/2004

Authorization holder

Merck (Schweiz) AG

6300 Zug

Authorization information

Swissmedic authorization number
56364
Drug name
Ovitrelle 250 µg, Injektionslösung in einer Fertigspritze
Galenic form
INLFS
ATC Code
G03GA08
Authorization status
Z
Dispensing category
A
First authorization
17/02/2004
Authorization expiration date
31/12/9999
IT Number
07.08.1.
Domain
Human medicine
Field of application
Induktion der Ovulation

Package details

Description (FR)
OVITRELLE sol inj 250 mcg/0.5 ml ser pré 0.5 ml
Description (DE)
OVITRELLE Inj Lös 250 mcg/0.5 ml Fertspr 0.5 ml
Market launch
17/02/2004
Narcotic (BTM)
No